Cargando…
Sub-differentiation of PI-RADS 3 lesions in TZ by advanced diffusion-weighted imaging to aid the biopsy decision process
BACKGROUND: Performing biopsy for intermediate lesions with PI-RADS 3 has always been controversial. Moreover, it is difficult to differentiate prostate cancer (PCa) and benign prostatic hyperplasia (BPH) nodules in PI-RADS 3 lesions by conventional scans, especially for transition zone (TZ) lesions...
Autores principales: | Zhou, Kun-Peng, Huang, Hua-Bin, Bu, Chao, Luo, Zhong-Xing, Huang, Wen-Sheng, Xie, Li-Zhi, Liu, Qing-Yu, Bian, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950630/ https://www.ncbi.nlm.nih.gov/pubmed/36845749 http://dx.doi.org/10.3389/fonc.2023.1092073 |
Ejemplares similares
-
Improving the understanding of PI-RADS in practice: characters of PI-RADS 4 and 5 lesions with negative biopsy
por: Wang, Yu-Hao, et al.
Publicado: (2023) -
Combining clinical and MRI data to manage PI-RADS 3 lesions and reduce excessive biopsy
por: Yang, Shuo, et al.
Publicado: (2020) -
Evidence for a $(K \pi \pi)$ resonance with $T_z$ = $\pm 3/2$ at 1270 MeV
por: Böck, R K, et al.
Publicado: (1964) -
The Application of Biopsy Density in Transperineal Templated-Guided Biopsy Patients With PI-RADS<3
por: Zhu, Hai, et al.
Publicado: (2022) -
Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy?
por: Gomez-Gomez, Enrique, et al.
Publicado: (2021)